The global prevalence of migraine as a primary headache has been estimated as 14.4% in
both sexes. Migraine headache has been ranked as the highest contributor to disability in …

The aim was to capture interdisciplinary expertise from a large group of clinicians, reflecting
practice from across the UK and further, to inform subsequent development of a national …

Objective The development of these updated clinical practice guidelines (CPG) was
commissioned by the American Association of Clinical Endocrinologists, The Obesity …

Abstract Background Idiopathic Intracranial Hypertension (IIH) is characterized by an
elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely …

Idiopathic intracranial hypertension is a neurological syndrome determined by a rise in
intracranial pressure without a detectable cause. Course and prognosis may be …

Purpose of Review Idiopathic intracranial hypertension (IIH) prevalence increased in
conjunction with rising obesity rates. Here, we highlight the importance of weight …

Abstract Treatment options for idiopathic intracranial hypertension are limited. The enzyme
11β-hydroxysteroid dehydrogenase type 1 has been implicated in regulating cerebrospinal …

Background While venous congestion in the peripheral vasculature has been described and
accepted, intracranial venous congestion remains poorly understood. The characteristics …

Purpose Idiopathic intracranial hypertension (IIH) is a rare disorder characterised by raised
intracranial pressure. The underlying pathophysiology is mostly unknown and effective …

Advances in ophthalmic diagnostics and results of interventional clinical trials are shifting
diagnosis and management of idiopathic intracranial hypertension (IIH) to be more …